Soergel David
Chief Medical Officer at MDGL; Sr. VP,Clinical Dev. & CMO at TREVENA INC
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jun 1, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MDGLMADRIGAL PHARMACEUTICALS, INC.Chief Medical Officer
- TREVENA INCSr. VP,Clinical Dev. & CMO
Sales by reason
1
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- TREVENA INC27,217 shares
- MDGL1,886 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale TREVENA INCUnusualDec 10, 2015 2015
Sold 27,217 shares at $10.55 ($287k)
Soergel David, Sr. VP,Clinical Dev. & CMO
Sold 94% of holdings ($306k position)1,750 shares leftFirst sale on recordFiling
- 2 Form 4 sale MDGLNo planMay 18, 2026 +3812 days
Sold 844 shares at $515.90 ($435k)
Soergel David, Chief Medical Officer
No 10b5-1 planSold 7.1% of holdings ($6.1M position)11,075 shares leftFirst sale on recordFiling
- 3 Form 4 sale MDGLRoutineJun 1, 2026 +14 days
Sold 1,042 shares at $495.74 ($517k)
Soergel David, Chief Medical Officer
10b5-1 planSold 9.4% of holdings ($5.5M position)10,033 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 1, 2026 | MDGL | Chief Medical Officer | Form 4 sale | 1,042 | $517k | 9.4% | Routine | SEC |
| May 18, 2026 | May 18, 2026 | MDGL | Chief Medical Officer | Form 4 sale | 844 | $435k | 7.1% | No plan | SEC |
| Dec 10, 2015 | Dec 11, 2015 | TREVENA INC | Sr. VP,Clinical Dev. & CMO | Form 4 sale | 27,217 | $287k | 94.0% | Unusual | SEC |